Purpose of the Procedure
- Assisting in the diagnosis of mature cystic teratomas (Dermoid Cysts).
- Evaluating the severity of endometriosis cases.
- Monitoring ovarian health before and after surgical interventions.
Book CA 19-9 Ovarian Marker Test | Lahalak Medical Platform
This diagnostic test assists in identifying mature cystic teratomas and severe endometriosis, ensuring accurate clinical insights for early management of your reproductive health and long-term physical well-being.
Scientific name: Carbohydrate Antigen 19-9 (CA 19-9) Test
A laboratory test measuring CA 19-9 protein levels in the blood. It serves as a diagnostic adjunct for mature cystic teratomas and severe endometriosis to evaluate ovarian health effectively.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Blood sample collection
- CA 19-9 lab analysis
- Results report
Medical Service Information
Target Groups
- Women experiencing chronic pelvic pain.
- Patients with suspected ovarian cysts identified via ultrasound.
- Women monitoring treatment for severe endometriosis.
Clinical Significance
- CA 19-9 acts as a vital diagnostic adjunct to imaging for higher accuracy.
- Helps differentiate between various types of benign ovarian tumors.
- Provides a quantitative marker to track response to medical or surgical therapy.
Conditions & Notices
- No fasting is required before the test
Medical services you might also like
